Market News & Trends
Drug R&D Costs: $1.7 Billion & Rising
The significant costs of developing new, life-saving drugs and treatments has reached over $1.7 billion per drug over a span of 10-12 years. The mounting…
Recipharm Makes Strategic Investment in Synthonics
Recipharm recently announced it has made an equity investment in Synthonics Inc and purchased $2 million of preferred stock in the company. A further $2…
Melanoma Treatment Market Value to More Than Quadruple to $5.64 Billion
The global treatment market for melanoma will expand more than four-fold in value from $1.34 billion in 2013 to reach an estimated $5.64 billion by…
Edge Therapeutics Raises $72.5 Million to Advance Pipeline
Edge Therapeutics recently announced it has raised approximately $72.5 million in gross proceeds from two recently completed private financing rounds. The most recent round, a…
Protea Announces Acquisition Agreement to Develop & Market New Services
Protea Biosciences Group, Inc. recently announced it has entered into an agreement dated as of March 31, 2015, for the purchase of vivoPharm Pty Ltd.,…
PhoreMost Ltd Founded to Identify New Druggable Targets for Therapeutics
PhoreMost Ltd has been founded to identify new druggable targets for cancer and other unmet diseases. Based in Cambridge, UK, PhoreMost announced it has successfully…
Foster Polymer Distribution Announces Official Partnership
Foster Polymer Distribution, a business unit of Foster Corporation specializing in the distribution of medical polymers and additives, recently announced its official partnership with Mitsubishi…
Catalent Pharma Solutions Joins Pharma & Biopharma Outsourcing Association
The Pharma & Biopharma Outsourcing Association (PBOA) recently announced that Catalent Pharma Solutions has joined the PBOA as a Sustaining Member. Cornell Stamoran, Vice President,…
Alzheon Announces $10-Million Financing to Advance Lead Drug Candidate
Alzheon, Inc. recently announced it has closed a $10-million Series A financing round. This equity financing was led by Ally Bridge Group and included investments…
Top Mid-Cap Biotech Companies Increased Revenues to $26.5 Billion in 2014
The combined total revenues for the peer group of 35 mid-cap biotech companies increased from $24.8 billion in 2013 to $26.5 billion in 2014, representing…
PlasmaTech Biopharmaceuticals' Partner Receives Marketing Approval
PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI) recently announced that its Korean marketing partner, Hanmi Pharmaceutical Co., Ltd has received marketing approval in Korea from the country's…
Metrics Contract Services Invests in Equipment to Help Clients Meet New USP for Impurities
Metrics Contract Services (Metrics) has purchased state-of-the-art analytical laboratory equipment to better serve pharmaceutical clients whose drug products now must undergo heightened elemental impurities testing,…
TraceLink Joins PBOA: New Affiliate Member Brings Serialization Expertise
The Pharma & Biopharma Outsourcing Association (PBOA) recently announced that TraceLink, Inc. has joined the PBOA as an Affiliate Member. Affiliate companies provide services and…
Catalent Acquires Pharmapak, Australia
Catalent Pharma Solutions recently announced it has acquired Pharmapak Technologies Pty Ltd., a leading pharmaceutical packaging business based in New South Wales, Australia. Enhancing Catalent’s…
Althea's New Drug Formulation Technology Gains Attention from Two More Top Pharmaceutical Companies
Ajinomoto Althea, Inc. (Althea) recently announced it has added two more top pharmaceutical companies to its growing list of partners in developing and manufacturing cGMP-produced…
Aptar Pharma Twister® Chosen for Asthma Therapy
Louveciennes, France - Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products…
TPG Completes Acquisition of Aptalis Pharmaceutical Technologies, Company Renamed Adare
BRIDGEWATER, New Jersey and FORT WORTH, Texas – Aptalis Pharmaceutical Technologies recently announced that its divestiture from Actavis plc to TPG, a global…
Development & Commercialization of Antibacterial Drugs to Speed Up
The growing threat posed by multi-drug resistant gram-negative organisms (MDR-GNBs) is lending a sense of urgency to the development of antibacterial drugs worldwide. Upcoming regulatory…
US Rheumatoid Arthritis Treatment Market Value to Reach $9.3 Billion
The US treatment market for Rheumatoid Arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, representing…
Irvine’s ResearchDx Signs Agreement With Micron, Inc.
ResearchDx, Inc. of Irvine, California and Micron Inc. of Tokyo, Japan have entered into an agreement for international collaborative clinical trials. The in vitro diagnostic…
